News
Cell therapy promising as long-term limb-saving treatment in diabetes
- Author:
- Sara Freeman
Fewer amputations were needed at 5 years in patients with diabetic foot and critical limb-threatening ischemia, compared with conservative...
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Retinopathy risk higher in young-onset T2D, more so in men
- Author:
- Sara Freeman
Gender differences in the prevalence of retinopathy have been seen in a large Norwegian population of primary care patients with type 2 diabetes...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Ho_Frederick_GLASGOW_web.jpg)
‘Metabolically healthy obesity’ tied to substantial heart risk
- Author:
- Sara Freeman
There was an increased risk for both new-onset heart failure and atrial fibrillation in people who were obese with no metabolic abnormalities.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Patorno_Elisabetta_web.jpg)
Heart failure hospitalization risk lower with SGLT2 inhibitors than GLP-1 RAs
- Author:
- Sara Freeman
SGLT2 inhibitor versus GLP-1 RA use was associated with a significantly lower rate of hospitalization for heart failure in people with diabetes....
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Reveille_John_D_TX_web.jpg)
Early vs. late TNFi switch in AS patients associated with different risk factors
- Author:
- Sara Freeman
Different factors were associated with switching an initial TNF inhibitor within 2 years versus after 2 years of treatment.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/van der Heijde_Desiree_NETH2_web_0.jpg)
Real-world data generate debate on definition of flare in axial spondyloarthritis
- Author:
- Sara Freeman
Changes in the Bath Ankylosing Spondyloarthritis Disease Activity Index could be used to monitor patient-reported flares in axial...
News
Targeting IL-23 could still be important for axial spondyloarthritis treatment
- Author:
- Sara Freeman
Results of a systematic review and meta-analysis corroborate negative trial findings for IL-23 but hint at some early benefit with risankizumab....
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/Landewe_Robert_NETHERLANDS_web.jpg)
csDMARDs could add to TNF inhibitors’ benefits in SpA
- Author:
- Sara Freeman
EuroSpA Research Collaboration data hint at better retention and remission rates with csDMARD-TNFi cotherapy versus TNFi alone in...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Helliwell_Philip_UK_2_web.jpg)
Biologic benefit in psoriasis might extend to arthritis prevention
- Author:
- Sara Freeman
People with psoriasis had a lower risk for psoriatic arthritis if they had been treated with a biologic than if they had not, based on a study of...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/spinal_xray_DXA_web.jpg)
Vertebral fractures still a risk with low-dose oral glucocorticoids for RA
- Author:
- Sara Freeman
Vertebral, not other, osteoporotic fractures were increased in current versus past users of low-dose steroids in a retrospective cohort study.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/August-2018/pills_520225198_web.jpg)
Pharmacovigilance data implicate three new drugs in ANCA-associated vasculitis
- Author:
- Sara Freeman
Mirabegron, sofosbuvir, and nintedanib join a list of 12 other drugs that have been linked to an overreporting of drug-associated ANCA vasculitis...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2018/Poddubnyy_Denis_GERMANY_2_web.jpg)
TNF inhibitors have delayed effect on spondyloarthritis radiographic progression
- Author:
- Sara Freeman
It could take 2-4 years before plain radiographs show any sign of a benefit on the spine or sacroiliac joints.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/SchulzeKoops_Hendrik_EULAR_web.jpg)
Mavrilimumab may aid severe COVID-19 recovery
- Author:
- Sara Freeman
The granulocyte/macrophage-colony stimulating factor (GM-CSF) blocker reduced the need for mechanical ventilation and death by day 29 versus...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Sparks_Jeffrey_A_MA_web.jpg)
Patients with RA on rituximab at risk for worse COVID-19 outcomes
- Author:
- Sara Freeman
Risk mitigation strategies such as social distancing and wearing masks, especially indoors, remain important for people being treated with...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2018/Coates_Laura_UK_web.jpg)
GRAPPA refines recommendations on psoriatic disease treatment
- Author:
- Sara Freeman
Biosimilars, Janus kinase inhibitors, and interleukin-23 inhibitors will feature in the 2021 update.